72 Results

People

  1. Adusumilli
    Adusumilli
  2. Eguchi
    Eguchi
  3. Travis
    Travis
  4. Jones
    Jones
  5. Tan
    Tan
  6. Rekhtman
    Rekhtman
  7. Lu
    Lu
  8. Sadelain
    Sadelain
  9. Morello
    Morello
  10. Rusch
    Rusch

Groups

  1. Sloan Kettering Institute Postdocs (72)
  2. Surgery (72)
  3. Biostatistics Service (24)
  4. Epidemiology and Biostatistics (24)
  5. Department of Medicine (18)
  6. GSK Faculty (15)
  7. Molecular Pharmacology and Chemistry Program Faculty (12)
  8. Sloan Kettering Institute Faculty (12)
  9. Center for Hematologic Malignancies (11)
  10. Hematologic Malignancies Research (11)
  1. "Meeting abstract"
  2. "Sloan Kettering Institute Postdocs"
  3. "Prasad Adusumilli"
Formats
  1. Meeting Abstract (72)
Groups
  1. Sloan Kettering Institute Postdocs (72)
  2. Surgery (72)
  3. Biostatistics Service (24)
  4. Epidemiology and Biostatistics (24)
  5. Department of Medicine (18)
  6. GSK Faculty (15)

More Groups

People
  1. Prasad Adusumilli (72)
  2. Takashi Eguchi (42)
  3. William Travis (34)
  4. David Jones (32)
  5. Kay See Tan (23)
  6. Natasha Rekhtman (15)

More People

Years
  1. 2023 (2)
  2. 2021 (2)
  3. 2020 (5)
  4. 2019 (6)
  5. 2018 (13)
  6. 2017 (27)

More Years

Publications
  1. Journal of Thoracic Oncology (47)
  2. Modern Pathology (6)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Journal of Clinical Oncology (3)
  5. Journal of the American College of Surgeons (3)
  6. Laboratory Investigation (3)

More Publications

Publishers
  1. Elsevier Inc. (50)
  2. Nature Research (6)
  3. Elsevier Science, Inc. (4)
  4. American Society of Clinical Oncology (3)
  5. Nature Publishing Group (3)
  6. American Association for Cancer Research (1)

More Publishers

Results (72)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR T-cell intrinsic PD1 dominant negative receptor (PD1DNR) functions by both cell-intrinsic and extrinsic mechanisms
    Meeting Abstract

    Amador, A.; Hou, Z.; Chintala, N.; Adusumilli, P. S.
    Journal of Immunology (2023)

    Fulltext@MSK | Save
  • High-risk clinicopathologic and genomic features of recurrence in stage I lung adenocarcinoma
    Meeting Abstract

    Fick, C. N.; Dunne, E. G.; Mastrogiacomo, B.; Tan, K. S.; Toumbacaris, N.; Adusumilli, P. S.; Rocco, G.; Molena, D.; Huang, J.; Park, B. J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Validation of the 8th ed TNM: Invasive size for pathologic T descriptor in stage I-IIA resected nonmucinous adenocarcinomas
    Meeting Abstract

    Li, Y.; Choe, J.; Tan, K. S.; Cheema, W.; Rekhtman, N.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial
    Meeting Abstract

    Kiesgen, S.; Linot, C.; Quach, H. T.; Saini, J.; Bellis, R.; Banerjee, S.; Hou, Z.; Chintala, N. K.; Sadelain, M.; Adusumilli, P. S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Sustained, cell-intrinsic versus intermittent, cell-extrinsic checkpoint blockade in solid tumor CAR T-cell therapy
    Meeting Abstract

    Linot, C.; Saini, J.; Adusumilli, P. S.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Histologic patterns of lung adenocarcinoma reported on biopsy accurately predict composition of resected tumor
    Meeting Abstract

    Baine, M.; Travis, W.; Buonocore, D.; Chang, J.; Daniel, G.; Rekhtman, N.; Adusumilli, P.; Sauter, J.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • A genomically adjusted clinicopathologic model predicts recurrence in resected early-stage lung squamous cell carcinoma
    Meeting Abstract

    Connolly, J. G.; Tan, K. S.; Sanchez-Vega, F.; Jones, G. D.; Liu, Y.; Caso, R.; Rocco, G.; Park, B. J.; Adusumilli, P. S.; Molena, D.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Irreversible electroporation can selectively ablate cancer cells without affecting proliferation or effector function of chimeric antigen receptor engineered T cells
    Meeting Abstract

    Srimathveeravalli, G.; Vista, W.; Fujimori, M.; Collins, S.; Linot, C.; Dozier, J.; Solomon, S.; Adusumilli, P.
    Journal of Vascular and Interventional Radiology (2020)

    Fulltext@MSK | Save
  • Clinical rationale and preclinical evidence for chimeric antigen receptor (CAR) T cell therapy clinical trial in KRAS-mutant lung cancer
    Meeting Abstract

    Minehart, J.; Eguchi, T.; Morello, A.; Adusumilli, P.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save